A practical method to calibrate self-reported adherence to antiretroviral therapy

Journal of Acquired Immune Deficiency Syndromes

Volumn 43, Issue SUPPL. 1, 2006, Pages

  Liu, Honghu ^a   Miller, Loren G ^b   Hays, Ron D ^a   Wagner, Glenn ^c   Golin, Carol E ^d   Hu, Wenhua ^e   Kahn, Katherine ^a   Haubrich, Richard ^f   Kaplan, Andrew H ^d   Wenger, Neil S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c RAND CORPORATION   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Calibration model; Cross validation; Predicted residual sum of squares; Self reported adherence

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACCURACY; ADULT; ARTICLE; CALIBRATION; COHORT ANALYSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT; TREATMENT DURATION; TREATMENT REFUSAL;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MODELS, THEORETICAL; PATIENT COMPLIANCE; REPRODUCIBILITY OF RESULTS;

EID: 33845358392     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000245888.97003.a3     Document Type: Article

References (35)

1. Haubrich RH, Little SJ, Currier JS, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group. AIDS. 1999;13:1099-1107.
2. Paterson L, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21-30.
3. Liu HH, Golin CG, Miller L, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134:968-977.
4. Knobel H, Carmona A, Grau S, et al. Adherence and effectiveness of highly active antiretroviral therapy. Arch Intern Med. 1998;158:1953.
5. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load and development of drug resistance in an indigent population. AIDS. 2000;14:357-366.
6. Kalichman SC, Cain D, Cherry C, et al. Pillboxes and antiretroviral adherence: prevalence of use, perceived benefits, and implications for electronic medication monitoring devices. AIDS Patient Care STDS. 2005;19:833-839.
7. Waterhouse DM, Calzone KA, Mele C, et al. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts and microelectronic monitoring. J Clin Oncol. 1993;11:1189-1197.
8. Grymonpre RE, Didur CD, Montgomery PR, et al. Pill count, self-report and pharmacy claims data to measure medication adherence in the elderly. Ann Pharmacother. 1998;32:749-754.
9. Burney KD, Krishnan K, Ruffin MT, et al. Adherence to single daily dose of aspirin in a chemoprevention trial. An evaluation of self-report and microelectronic monitoring. Arch Fam Med. 1996;5:297-300.
10. Mason BJ, Matsuyama JR, Jue SG. Assessment of sulfonylurea adherence and metabolic control. Diabetes Educ. 1995;21:52-57.
11. Liu HH, Miller LG, Hays RD, et al. A comprehensive evaluation of survey questions for adherence to antiretroviral medications and exploratory analyses for identifying optimal sets of survey questions. AIDS Patient Care STDS. (In press).
12. Wagner J, Miller LG. Is the influence of social desirability on patients' self-reported adherence overrated? [letter]. J Acquir Immune Defic Syndr. 2004;35:203-204.
13. Nieuwkerk PT. Does electronic monitoring of adherence reduce social desirability on patients' self-reports of adherence? [letter]. J Acquir Immune Defic Syndr. 2004;36:880.
14. Beresford TP. Screening for alcohol abuse using the CAGE questionnaire. Am J Med. 1987;83:805.
15. Liskow B, Campbell J, Nickel EJ, et al. Validity of the CAGE questionnaire in screening for alcohol dependence in a walk-in (triage) clinic. J Stud Alcohol. 1995;56:277-281.
16. Oyugi JH, Byakika-Tusiime J, Charlebois ED, et al. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting. J Acquir Immune Defic Syndr. 2004;36:1100-1102.
17. Bangsberg DR, Ware N, Simoni J. Adherence without access to antiretroviral therapy in sub-Saharan Africa. AIDS. 2006;20:140-141.
18. Crane J, Kawuma A, Oyugi J, et al. The price of adherence: qualitative findings from patients purchasing fixed-dose combination generic HIV antiretroviral therapy in Kampala, Uganda. AIDS Behav. 2006;10:437-442.
19. View MEMS. User's Guide (Version 2.61). Union City, CA: APREX, Intelligent Technology for Medication Management; 1998.
20. Miller LG, Liu HH, Hays RD, et al. Knowledge of antiretroviral regimen and medication adherence. Clin Infect Dis. 2003;36:514-518.
21. Golin C, Liu HH, Hays R, et al. Attitude and demographic factors associated with antiretroviral adherence. J Gen Intern Med. 2002;17:1-10.
22. Wagner GJ, Kanouse DE, Golinelli D, et al. Cognitive-behavioral intervention to enhance adherence to ART: a randomized controlled trial (CCTG 578). AIDS. (In press).
23. Swierenga H, deWeijer AP, van Wijk RJ, et al. Strategy for constructing multivariate calibration models. Chemom Intell Lab Syst. 1999;49:1-17.
24. Borovnicar DJ, Stroud DB, Bines JE, et al. Comparison of total body chlorine, potassium, and water measurements in children with cystic fibrosis. Am J Clin Nutr. 2000;71:36-43.
25. Tosi S, Rossi M, Tamburini E, et al. Assessment of in-line near-infrared spectroscopy for continuous monitoring of fermentation processes. Biotechnol Prog. 2003;19:1816-1821.
26. Brien WF, Crawford L, Raby A, et al. In-house calibration of the international sensitivity index or calibration curve for determination of the international normalized ratio. Arch Pathol Lab Med. 2004;128:308-312.
27. Swierenga H, de Weijer AP, van Wijk RJ, et al. Strategy for constructing robust multivariate calibration models. Chemom Intell Lab Syst. 1999;49:1-17.
28. Stone M. Cross-validation choice and assessment of statistical predictions. Journal of the Royal Statistical Society, Series B. 1974;111-147.
29. Geisser S. The predictive sample reuse method with applications. Journal of the American Statistical Association. 1975;74:153-160.
30. Shao J. Linear model selection by cross-validation. Journal of the American Statistical Association. 1992;88:486-492.
31. Efron B. Estimating the error rate of a prediction rule: Improvement on cross-validation. Journal of the American Statistical Association. 1983;78:316-331.
32. Allen DM. Mean square error of prediction as a criterion for selecting variables. Technometrics. 1971;13:469-475.
33. Liu HH, Weiss RE, Jennrich IR, et al. PRESS model selection for repeated measures data. Journal of Computational Statistics and Data Analysis. 1999;30:169-184.
34. Rigsby MO, Rosen MI, Beuvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Intern Med. 2000;15:891-893.
35. Mannheimer S, Friedland G, Matts J, et al. The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus infected persons in clinical trials. Clin Infect Dis. 2002;34:1115-1121.